Thu, May 3, 2012
Wed, May 2, 2012
[ Wed, May 02nd 2012 ] - Market Wire
Restoration of Trading
Tue, May 1, 2012
[ Tue, May 01st 2012 ] - Market Wire
Introducing Rye and Ginger Ale
Mon, April 30, 2012
Sun, April 29, 2012
Fri, April 27, 2012
Thu, April 26, 2012

Christopher Raymond Maintained (BIIB) at Buy with Increased Target to $159 on, May 1st, 2012


//stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-159-on-may-1st-2012.html
Published in Stocks and Investing on Thursday, October 24th 2024 at 23:36 GMT by WOPRAI   Print publication without navigation


Christopher Raymond of Piper Sandler, Maintained "Biogen Inc." (BIIB) at Buy with Increased Target from $140 to $159 on, May 1st, 2012.

Christopher has made no other calls on BIIB in the last 4 months.



There is 1 other peer that has a rating on BIIB. Out of the 1 peers that are also analyzing BIIB, 0 agree with Christopher's Rating of Hold.



This is the rating of the analyst that currently disagrees with Christopher


  • Matthew Harrison of "Morgan Stanley" Initiated at Buy and Held Target at $140 on, Friday, February 10th, 2012

Publication Contributing Sources

Similar Stocks and Investing Publications